Increased immunogenicity to P815 cells modified with malondialdehyde and acetaldehyde.
Aldehyde modified proteins have been associated with the development and/or progression of alcoholic liver disease (ALD). These protein adducts are capable of initiating many immunological responses that are harmful to the normal homeostasis of organism function. Previous studies have shown that malondialdehyde (MDA) and acetaldehyde (AA) synergistically form a unique adduct (MAA) with soluble proteins, which are capable of inducing cytokine release, T-cell proliferation, and antibody production. The purpose of this study was to determine whether MAA adduction can elicit similar responses to cells using a well-defined tumor model. The mouse mastocytoma P815 tumor cell line was modified with MAA (P815-MAA) or left unmodified (P815) and 10(6) irradiated cells were injected into DBA/2 mice once a week for 5 weeks. Serum was collected and tested for antibody responses to P815 cells and the MAA epitope. Immunization of MAA adducted P815 cells into syngeneic DBA/2 mice induced a strong antibody response to the MAA epitope as determined by ELISA on Alb and MAA-Alb (508 microg/ml and 1092 microg/ml, respectively). In addition, antibody to unmodified P815 cells was detected by fluorescent technique. Mice immunized with P815 cells or PBS showed little or no reactivity to the MAA epitope or P815 cells. Studies to assess IL-12 stimulation showed that peritoneal macrophages from P815 and PBS immunized animals produced modest amounts of IL-12 (20 and 35 pg/ml) when stimulated with Alb or MAA-Alb. However, macrophage from P815-MAA immunized mice responded to soluble MAA adduct (142 pg/ml). Finally, in tumor survival studies the mean survival was 14.25 days in PBS treated mice; 15.75 days with P815 immunized mice and 18.25 days with P815-MAA immunized mice. Therefore, these data strongly suggest that antibody responses are induced by P815 cells modified with MAA adducts. This may be a possible tool to begin looking at how alcohol metabolites potentially modify cells and/or cellular components making them recognizable to the immune system as foreign. It is thought that these studies define a model system that will be useful in assessing antibody and potentially T-cell responses to cells that are modified by MAA.
University of Nebraska Medical Center, Department of Internal Medicine, 983025 Nebraska Medical Center, Omaha, NE 68198-3025, United States. mduryee@unmc.edu
Michael J
MJ
Duryee
Lynell W
LW
Klassen
Bonnie L
BL
Jones
Monte S
MS
Willis
Dean J
DJ
Tuma
Geoffrey M
GM
Thiele
D000079:Acetaldehyde / Q000276:immunology / Q000378:metabolism*; D000818:Animals; D000912:Antibodies, Neoplasm / Q000097:blood* / Q000276:immunology; D045744:Cell Line, Tumor; D007114:Immunization; D018664:Interleukin-12 / Q000276:immunology / Q000378:metabolism*; D017737:Macrophages, Peritoneal / Q000276:immunology* / Q000378:metabolism; D008315:Malondialdehyde / Q000276:immunology / Q000378:metabolism*; D034801:Mastocytoma / Q000276:immunology* / Q000378:metabolism / Q000401:mortality; D051379:Mice; D008811:Mice, Inbred DBA; D009368:Neoplasm Transplantation
D000912:Antibodies, Neoplasm; D018664:Interleukin-12; D008315:Malondialdehyde; D000079:Acetaldehyde